Clickable Table

< back to the main pricing table
Generic Name Brand Name Strength Dosing 90 Day Cost Coverage Comments Category 1 Category 2
Glyburide Diabeta 5 mg BID $25 BC / NIHB - Covered Hypoglycemic Agents Sulfonylureas
Gliclazide MR Diamicron MR 30 mg MR 2 QD $35 BC / NIHB - Covered Hypoglycemic Agents Sulfonylureas
Semaglutide Ozempic 1 mg SQ Once weekly $525 BC / NIHB - SA Hypoglycemic Agents Glucagon-like Peptide 1 Agonist (GLP-1)
Liraglutide Victoza 1.2 mg SQ QD $730 BC / NIHB - NC Hypoglycemic Agents Glucagon-like Peptide 1 Agonist (GLP-1)
Gliclazide Diamicron 80 mg BID $35 BC / NIHB - Covered Hypoglycemic Agents Sulfonylureas
Rapid-acting insulin Humalog 100 U/ml As dir $100 BC - NC / NIHB - SA Hypoglycemic Agents Insulin
Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).
Metformin Glucophage 500 mg 2 BID $25 BC / NIHB - Covered Hypoglycemic Agents Biguanides
Basal insulin (Glargine) Lantus 100 U/ml As dir $120 BC - NC / NIHB - SA Hypoglycemic Agents Insulin
Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).
Rapid-acting insulin biosimilars Trurapi 100 U/ml As dir $65 BC / NIHB - Covered Hypoglycemic Agents Insulin
Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).
Dapagliflozin Propanediol Monohydrate Forxiga 10 mg QD $80 BC / NIHB - Covered Hypoglycemic Agents Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
Basal insulin (Degludec) Tresiba 100 U/ml As dir $135 BC / NIHB - Covered Hypoglycemic Agents Insulin
Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).
Linagliptin Trajenta 5 mg QD $280 BC - SA / NIHB - Covered Hypoglycemic Agents Dipeptidylpeptidase-4 Inhibitors (DPP-4)
Liraglutide Victoza 1.8 mg SQ QD $1090 BC / NIHB - NC Hypoglycemic Agents Glucagon-like Peptide 1 Agonist (GLP-1)
Repaglinide Gluconorm 1 mg TID $40 BC / NIHB - Covered Hypoglycemic Agents Meglitinides
Metformin SR Glumetza SR 1000 mg 2 QD $290 BC - NC / NIHB - SA Hypoglycemic Agents Biguanides
Sitagliptin Januvia 100 mg QD $95 BC / NIHB - SA Hypoglycemic Agents Dipeptidylpeptidase-4 Inhibitors (DPP-4)
Canagliflozin Invokana 100 mg QD $295 BC / NIHB - SA Hypoglycemic Agents Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
Rapid-acting insulin Apidra 100 U/ml As dir $75 BC / NIHB - Covered Hypoglycemic Agents Insulin
Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).
Rapid-acting insulin biosimilars Admelog 100 U/ml As dir $65 BC / NIHB - Covered Hypoglycemic Agents Insulin
Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).
Rapid-acting insulin Novorapid 100 U/ml As dir $85 BC - NC / NIHB - SA Hypoglycemic Agents Insulin
Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).
Empagliflozin Jardiance 10 mg, 25 mg QD $290 BC - SA / NIHB - Covered Hypoglycemic Agents Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
Basal insulin biosimilar (Glargine) Basaglar 100 U/ml As dir $100 BC / NIHB - Covered Hypoglycemic Agents Insulin
Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).
Basal insulin (Glargine) Toujeo 300 U/ml As dir $115 BC - NC / NIHB - Covered Hypoglycemic Agents Insulin
Prices may vary between pharmacies, relative differences likely consistent. Max allowable price for 1500 Units of penfill insulin. Lantus, Novorapid, and Humalog part of Blue Cross biosimilar initiative so only biosimilar alternatives are covered (Basaglar, Trurapi, and Admelog, respectively).
Legend:
BC = Alberta Blue Cross, NIHB = Non-Insured Health Benefits for First Nations and Inuit, NC = Not covered, SA = special authorization